Cargando…

Expression of selected genes of dendritic and Treg cells in blood and skin of morphea patients treated with UVA1 phototherapy

INTRODUCTION: Morphea is a chronic autoimmune disease characterized by fibrosis of the skin. Dendritic cells (DC) and regulatory T cells (Tregs) play a significant role in development of autoimmune and tolerance mechanisms. The aim of the study was to establish the expression of selected genes of pl...

Descripción completa

Detalles Bibliográficos
Autores principales: Osmola-Mańkowska, Agnieszka J., Teresiak-Mikołajczak, Ewa, Kowalczyk, Michał J., Żaba, Ryszard W., Adamski, Zygmunt, Dańczak-Pazdrowska, Aleksandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5868677/
https://www.ncbi.nlm.nih.gov/pubmed/29593811
http://dx.doi.org/10.5114/aoms.2018.73469
_version_ 1783309175364780032
author Osmola-Mańkowska, Agnieszka J.
Teresiak-Mikołajczak, Ewa
Kowalczyk, Michał J.
Żaba, Ryszard W.
Adamski, Zygmunt
Dańczak-Pazdrowska, Aleksandra
author_facet Osmola-Mańkowska, Agnieszka J.
Teresiak-Mikołajczak, Ewa
Kowalczyk, Michał J.
Żaba, Ryszard W.
Adamski, Zygmunt
Dańczak-Pazdrowska, Aleksandra
author_sort Osmola-Mańkowska, Agnieszka J.
collection PubMed
description INTRODUCTION: Morphea is a chronic autoimmune disease characterized by fibrosis of the skin. Dendritic cells (DC) and regulatory T cells (Tregs) play a significant role in development of autoimmune and tolerance mechanisms. The aim of the study was to establish the expression of selected genes of plasmacytoid and myeloid DC, Treg cells, and the microenvironment of cytokines (interleukin-17A (IL-17A), transforming growth factor β (TGF-β)) in blood and skin of morphea patients. In addition, the effect of UVA1 phototherapy on expression of the aforementioned genes was evaluated. MATERIAL AND METHODS: The study was performed on 15 blood and 10 skin samples from patients with morphea. The evaluation included expression of CLEC4C (C-type lectin domain family 4, member C receptor), Lymphocyte antigen 75 (LY75), Forkhead box p3 (foxp3) transcription factor, IL-17A and TGF-β genes in peripheral blood mononuclear cells (PBMC) and in skin samples both before and after UVA1 phototherapy using real-time polymerase chain reaction. RESULTS: The study revealed lower expression of CLEC4C before (p = 0.010) and after (p = 0.009) phototherapy and lower expression of IL-17A before (p = 0.038) phototherapy in PBMC of patients with morphea vs. the control group. Expression of CLEC4C in PBMC correlated negatively (rho = –0.90; p = 0.001) with activity of disease after phototherapy. No significant differences were found between expression of analysed genes before and after UVA1 therapy in PBMC and skin of morphea patients. CONCLUSIONS: The results do not confirm the involvement of analysed subsets of DC and Tregs in UVA1 phototherapy in morphea, but point to CLEC4C as a possible biomarker associated with the disease activity.
format Online
Article
Text
id pubmed-5868677
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-58686772018-03-28 Expression of selected genes of dendritic and Treg cells in blood and skin of morphea patients treated with UVA1 phototherapy Osmola-Mańkowska, Agnieszka J. Teresiak-Mikołajczak, Ewa Kowalczyk, Michał J. Żaba, Ryszard W. Adamski, Zygmunt Dańczak-Pazdrowska, Aleksandra Arch Med Sci Basic Research INTRODUCTION: Morphea is a chronic autoimmune disease characterized by fibrosis of the skin. Dendritic cells (DC) and regulatory T cells (Tregs) play a significant role in development of autoimmune and tolerance mechanisms. The aim of the study was to establish the expression of selected genes of plasmacytoid and myeloid DC, Treg cells, and the microenvironment of cytokines (interleukin-17A (IL-17A), transforming growth factor β (TGF-β)) in blood and skin of morphea patients. In addition, the effect of UVA1 phototherapy on expression of the aforementioned genes was evaluated. MATERIAL AND METHODS: The study was performed on 15 blood and 10 skin samples from patients with morphea. The evaluation included expression of CLEC4C (C-type lectin domain family 4, member C receptor), Lymphocyte antigen 75 (LY75), Forkhead box p3 (foxp3) transcription factor, IL-17A and TGF-β genes in peripheral blood mononuclear cells (PBMC) and in skin samples both before and after UVA1 phototherapy using real-time polymerase chain reaction. RESULTS: The study revealed lower expression of CLEC4C before (p = 0.010) and after (p = 0.009) phototherapy and lower expression of IL-17A before (p = 0.038) phototherapy in PBMC of patients with morphea vs. the control group. Expression of CLEC4C in PBMC correlated negatively (rho = –0.90; p = 0.001) with activity of disease after phototherapy. No significant differences were found between expression of analysed genes before and after UVA1 therapy in PBMC and skin of morphea patients. CONCLUSIONS: The results do not confirm the involvement of analysed subsets of DC and Tregs in UVA1 phototherapy in morphea, but point to CLEC4C as a possible biomarker associated with the disease activity. Termedia Publishing House 2018-02-21 2018-03 /pmc/articles/PMC5868677/ /pubmed/29593811 http://dx.doi.org/10.5114/aoms.2018.73469 Text en Copyright: © 2018 Termedia & Banach http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
spellingShingle Basic Research
Osmola-Mańkowska, Agnieszka J.
Teresiak-Mikołajczak, Ewa
Kowalczyk, Michał J.
Żaba, Ryszard W.
Adamski, Zygmunt
Dańczak-Pazdrowska, Aleksandra
Expression of selected genes of dendritic and Treg cells in blood and skin of morphea patients treated with UVA1 phototherapy
title Expression of selected genes of dendritic and Treg cells in blood and skin of morphea patients treated with UVA1 phototherapy
title_full Expression of selected genes of dendritic and Treg cells in blood and skin of morphea patients treated with UVA1 phototherapy
title_fullStr Expression of selected genes of dendritic and Treg cells in blood and skin of morphea patients treated with UVA1 phototherapy
title_full_unstemmed Expression of selected genes of dendritic and Treg cells in blood and skin of morphea patients treated with UVA1 phototherapy
title_short Expression of selected genes of dendritic and Treg cells in blood and skin of morphea patients treated with UVA1 phototherapy
title_sort expression of selected genes of dendritic and treg cells in blood and skin of morphea patients treated with uva1 phototherapy
topic Basic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5868677/
https://www.ncbi.nlm.nih.gov/pubmed/29593811
http://dx.doi.org/10.5114/aoms.2018.73469
work_keys_str_mv AT osmolamankowskaagnieszkaj expressionofselectedgenesofdendriticandtregcellsinbloodandskinofmorpheapatientstreatedwithuva1phototherapy
AT teresiakmikołajczakewa expressionofselectedgenesofdendriticandtregcellsinbloodandskinofmorpheapatientstreatedwithuva1phototherapy
AT kowalczykmichałj expressionofselectedgenesofdendriticandtregcellsinbloodandskinofmorpheapatientstreatedwithuva1phototherapy
AT zabaryszardw expressionofselectedgenesofdendriticandtregcellsinbloodandskinofmorpheapatientstreatedwithuva1phototherapy
AT adamskizygmunt expressionofselectedgenesofdendriticandtregcellsinbloodandskinofmorpheapatientstreatedwithuva1phototherapy
AT danczakpazdrowskaaleksandra expressionofselectedgenesofdendriticandtregcellsinbloodandskinofmorpheapatientstreatedwithuva1phototherapy